Epigenic Therapeutics is a startup. Brouky records 1 investor associated with the company.
Epigenic Therapeutics is a biotechnology company focused on discovering and developing therapeutics that target epigenetic mechanisms. It applies drug-discovery approaches to develop treatments for diseases driven by epigenetic dysregulation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.